Effects of Mediterranean Diet Based Intervention in Breast Cancer Patients
1 other identifier
interventional
78
0 countries
N/A
Brief Summary
The purpose of this randomized clinical trial is to examine the effects of Mediterranean diet based intervention on inflammation and metabolic risk factors in overweight or obese postmenopausal women with breast cancer receiving adjuvant hormone therapy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable breast-cancer
Started Aug 2019
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 25, 2019
CompletedStudy Start
First participant enrolled
August 1, 2019
CompletedFirst Posted
Study publicly available on registry
August 5, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2021
CompletedAugust 5, 2019
August 1, 2019
1 year
July 25, 2019
August 2, 2019
Conditions
Outcome Measures
Primary Outcomes (4)
Change in C-Reactive Protein (CRP) levels
Blood will be drawn from the participants for assessment of CRP levels (mg/L)
Baseline, 8 weeks
Change in fasting insulin levels
Blood will be drawn from the participants for assessment of fasting insulin levels (mcIU/mL) after fasting for at least 8 hours
Baseline, 8 weeks
Change in fasting glucose levels
Blood will be drawn from the participants for assessment of fasting glucose levels (mg/dL) after fasting for at least 8 hours
Baseline, 8 weeks
Change in lipid profile
Blood will be drawn from the participants for assessment of total cholesterol, triglyceride, HDL-cholesterol, and LDL-cholesterol (mg/dL) after fasting for at least 8 hours
Baseline, 8 weeks
Secondary Outcomes (4)
Change in body weight
Baseline, 8 weeks
Change in fat mass measured by bioelectrical impedance analyzer
Baseline, 8 weeks
Change in quality of life assessed by EORTC QLQ-C30 questionnaire
Baseline, 8 weeks
Change in quality of life assessed by OP scale questionnaire
Baseline, 8 weeks
Study Arms (2)
Mediterranean diet group
EXPERIMENTALMediterranean diet with calorie restriction below 1,500 kcal per day.
Conventional diet group
NO INTERVENTIONConventional diet with calorie restriction below 1,500 kcal per day.
Interventions
Two meals (breakfast and dinner) a day, five times a week, are delivered to participants' homes without charge. The meals are prepared, under the supervision of an expert nutritionist, by a chef trained on the principles of the Mediterranean diet.
Eligibility Criteria
You may qualify if:
- Breast cancer patients who are receiving adjuvant hormone therapy after diagnosed with breast cancer stage Ⅰ-Ⅲ and have completed cancer treatment including breast surgery and/or adjuvant chemotherapy, radiotherapy
- Postmenopausal women
- Body mass index (BMI) ≥23 kg/m2
- Able to speak and read Korean
- Able to comply with all required study procedures and schedule
- Willing and able to give written informed consent
You may not qualify if:
- Participants with cancer recurrence or metastasis
- Participants with weight change more than 5kg in the previous 3 months
- Participants with secondary causes of obesity, such as hypothyroidism
- Participants with hepatic disease (aspartate aminotransferase (AST)/alanine aminotransferase (ALT) \>3 x institutional upper limit of normal) or renal disease (serum creatinine \>2.0 mg/dL)
- Participants with serious psychiatric illness, including bipolar disorder, schizophrenia, or other psychosis, bulimia, anorexia nervosa, or suicidal ideation
- Participants who are taking weight loss medications
- Participants who are receiving systemic corticosteroid therapy
- Participants with alcohol abuse or dependence
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Related Publications (1)
Cho AR, Hong KW, Kwon YJ, Choi JE, Lee HS, Kim HM, Bae SJ, Ahn SG, Jeong J, Lee JW. Effects of Single Nucleotide Polymorphisms and Mediterranean Diet in Overweight or Obese Postmenopausal Women With Breast Cancer Receiving Adjuvant Hormone Therapy: A Pilot Randomized Controlled Trial. Front Nutr. 2022 Jul 1;9:882717. doi: 10.3389/fnut.2022.882717. eCollection 2022.
PMID: 35845810DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor, Department of Family Medicine
Study Record Dates
First Submitted
July 25, 2019
First Posted
August 5, 2019
Study Start
August 1, 2019
Primary Completion
August 1, 2020
Study Completion
August 1, 2021
Last Updated
August 5, 2019
Record last verified: 2019-08